Furthermore, the study conducted by Ying et al. indicates that CCT6A levels are correlated with a high metastasis potential in patients with high TGF-β levels, whereas in patients with low TGF-β levels, CCT6A expression is not associated with NSCLC metastasis. Here, CCT6A is linked to non-small cell lung carcinoma.